Search
                    Cisplatin Treatment Options in Maryland
A collection of 333 research studies where Cisplatin is the interventional treatment. These studies are located in the Maryland, United States. Cisplatin is used for conditions such as Head and Neck Cancer, Lung Cancer and Non-Small Cell Lung Cancer.
            289 - 300 of 333
        Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    
                
                                    Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of etoposide plus radiation therapy followed by combination chemotherapy in treating children with newly diagnosed advanced medulloblastoma.             
        
        
    Gender:
                ALL
            Ages:
                Between 3 years and 21 years
            Trial Updated:
                07/24/2014
            
            Locations: Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland  +1 locations         
        
        
            Conditions: Brain Tumors, Central Nervous System Tumors
        
            
        
    
                
                                    Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.
PURPOSE: This clinical trial is studying the side effects and best dose of zoledronic acid when given together with combination chemotherapy in treating patients with newly diagnosed metastatic osteosarcoma.             
        
        
    Gender:
                ALL
            Ages:
                40 years and below
            Trial Updated:
                06/04/2014
            
            Locations: Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, Baltimore, Maryland         
        
        
            Conditions: Sarcoma
        
            
        
    
                
                                    Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
                                
            
            
        Completed
                            
            
                RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which treatment regimen is more effective for endometrial cancer.
PURPOSE: Randomized phase III trial to compare radiation therapy with chemotherapy in treating patients who have advanced endometrial cancer.             
        
        
    Gender:
                FEMALE
            Ages:
                All
            Trial Updated:
                02/12/2014
            
            Locations: Johns Hopkins Oncology Center, Baltimore, Maryland         
        
        
            Conditions: Endometrial Cancer, Psychosocial Effects of Cancer and Its Treatment
        
            
        
    
                
                                    Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
                                
            
            
        Unknown
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known if treatment with cisplatin plus epinephrine is effective for head and neck cancer.
PURPOSE: Randomized double-blinded phase III trial to determine the effectiveness of cisplatin plus epinephrine in injectable gel form in treating patients who have recurrent or refractory head and neck cancer.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                12/18/2013
            
            Locations: Veterans Affairs Medical Center - Baltimore, Baltimore, Maryland         
        
        
            Conditions: Head and Neck Cancer
        
            
        
    
                
                                    Chemotherapy in Treating Patients With Liver Cancer
                                
            
            
        Unknown
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different ways may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of cisplatin and epinephrine administered directly into the tumor in treating patients who have primary liver cancer that cannot be removed during surgery.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                12/18/2013
            
            Locations: Johns Hopkins Oncology Center, Baltimore, Maryland         
        
        
            Conditions: Liver Cancer
        
            
        
    
                
                                    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of radiation therapy plus combination chemotherapy in treating patients with limited-stage small cell lung cancer.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 80 years
            Trial Updated:
                10/31/2013
            
            Locations: Anne Arundel Oncology Center, Annapolis, Maryland  +6 locations         
        
        
            Conditions: Lung Cancer
        
            
        
    
                
                                    Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy, such as docetaxel, cisplatin, fluorouracil, and carboplatin, work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. It is not yet known which regimen of chemotherapy and radiation therapy is most effective in treating head and neck cancer.
PURPOSE: Randomized phase III trial to compare the...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                10/25/2013
            
            Locations: Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland         
        
        
            Conditions: Head and Neck Cancer
        
            
        
    
                
                                    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I trial to study the effect on the body of combining cyclophosphamide with cisplatin, etoposide, and bleomycin in treating children who have newly diagnosed malignant germ cell tumors that are not in the brain and gonads.             
        
        
    Gender:
                ALL
            Ages:
                21 years and below
            Trial Updated:
                10/15/2013
            
            Locations: Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, Baltimore, Maryland         
        
        
            Conditions: Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
        
            
        
    
                
                                    Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC
                                
            
            
        Completed
                            
            
                This study is testing the investigational drug, cetuximab, in combination with different chemotherapy drugs for lung cancer. The aim of the study is to determine which of the drug combinations looks most promising and should be tested further. The study will also look at what side effects may occur.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                10/11/2013
            
            Locations: Not set, Baltimore, Maryland  +1 locations         
        
        
            Conditions: Non-Small Cell Lung Cancer
        
            
        
    
                
                                    Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer
                                
            
            
        Completed
                            
            
                Phase I trial to study the effectiveness of combining erlotinib with radiation therapy with or without cisplatin in treating patients who have advanced mouth or throat cancer. Erlotinib may stop the growth of tumor cells by blocking the enzymes necessary for their growth. Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining erlotinib with radiation therapy with or wi...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                09/27/2013
            
            Locations: Johns Hopkins University, Baltimore, Maryland         
        
        
            Conditions: Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage II Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Oropharynx
        
            
        
    
                
                                    Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
                                
            
            
        Completed
                            
            
                The purpose of this study is to identify an effective, well tolerated dose and schedule of romiplostim that is appropriate for the treatment of chemotherapy induced thrombocytopenia (CIT) in patients with non-small cell lung cancer receiving gemcitabine and platinum.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                09/18/2013
            
            Locations: Research Site, Baltimore, Maryland  +1 locations         
        
        
            Conditions: Lung Cancer, Chemotherapy-Induced Thrombocytopenia, Non-Small Cell Lung Cancer, Cancer, Lung Neoplasms, Oncology, Solid Tumors, Thrombocytopenia
        
            
        
    
                
                                    Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
                                
            
            
        Completed
                            
            
                This study will gather and compare data about the effectiveness and safety of two different treatments for extensive Small Cell Lung Cancer (SCLC) in patients who have not received previous chemotherapy. One treatment will use an investigational drug in combination with an FDA approved chemotherapy. The other treatment will use a combination of two FDA approved chemotherapy drugs.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/20/2013
            
            Locations: GSK Clinical Trials Call Center, Frederick, Maryland         
        
        
            Conditions: Small Cell Lung Cancer
        
            
        
    289 - 300 of 333
            